We are fast approaching the end of the first quarter of the year. Biotech is off to a nice start so far in 2017. The two stocks I profiled in an article in January entitled “Two Must Own Biotech Stocks For 2017" have done well and I believe will continue to do so. Today we look at two attractive small cap names with approaching catalysts that should be ‘must own’ names in the sector heading into the second quarter of the year.
